A team of US researchers, studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) said they have ...

People with a hidden heart condition may be at risk because current medical guidelines don't consider important personal ...

Better emergency action plans implemented by race organizers are keeping more runners who experience a cardiac arrest alive, ...

Lexeo Therapeutics, Inc.’s LXEO share price has dipped by 6.54%, which has investors questioning if this is right time to buy ...

We recently published a list of the 11 Most Promising Small-Cap Stocks According to Analysts. In this article, we are going ...

综合研究结果和讨论部分，该研究首次揭示了 SYT1 在心脏肥大中的重要保护作用。SYT1 缺乏会通过激活 p38 MAPK 通路，加重压力过载诱导的心脏肥大、纤维化、功能障碍以及心肌细胞凋亡。这一发现为深入理解心脏肥大的发病机制提供了新的视角，也为开发治疗心脏肥大的新策略提供了极具潜力的靶点，有望在未来为心血管疾病的治疗带来新的突破，具有重要的理论和临床意义。

A patient died after not receiving test results diagnosing him with cardiomyopathy; when should you settle a medical ...

Researchers have calibrated an AI algorithm to more specifically identify patients with hypertrophic cardiomyopathy (HCM), a ...